Scholarly Index
Jian‐xing Ma
Wake Forest University; 16,915 total citations; 454 total publications; best world rank #166
Wake Forest University
16,915Total citations
454Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Retinal Diseases and Treatments | Lifetime | 166 | US 87 | 99.27 |
| Retinal Development and Disorders | Lifetime | 224 | US 134 | 98.48 |
| Retinoids in leukemia and cellular processes | Lifetime | 374 | US 203 | 96.89 |
| Angiogenesis and VEGF in Cancer | Lifetime | 553 | US 250 | 96.80 |
| Advanced Glycation End Products research | Lifetime | 389 | US 107 | 95.22 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 687 | US 255 | 95.40 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 567 | US 236 | 94.41 |
| Corneal Surgery and Treatments | Lifetime | 686 | US 250 | 95.68 |
| Retinopathy of Prematurity Studies | Lifetime | 544 | US 240 | 89.76 |
| Connective Tissue Growth Factor Research | Lifetime | 920 | US 263 | 70.79 |
| Retinal Diseases and Treatments | 2021-2025 | 817 | US 215 | 92.63 |
| Retinal Development and Disorders | 2021-2025 | 411 | US 155 | 88.01 |
| Corneal Surgery and Treatments | 2021-2025 | 818 | US 148 | 78.65 |
| Advanced Glycation End Products research | 2021-2025 | 858 | US 91 | 60.23 |
| Retinopathy of Prematurity Studies | 2021-2025 | 859 | US 235 | 50.59 |